ID   GRS-IV
AC   CVCL_M785
SY   GRS IV
DR   Wikidata; Q54871699
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=15126569;
RX   PubMed=17786610;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M786 ! GRS-V
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
RX   CelloPub=CLPUB00412;
RA   Siddiqui Z.G.;
RT   "Medullary thyroid cancer: the current state of tumour marker and
RT   treatment strategies.";
RL   Thesis MD (2015); Medical University of Graz; Graz; Austria.
//
RX   PubMed=12089864;
RA   Pfragner R., Wirnsberger G.H., Ingolic E., Niederle B.;
RT   "Medullary thyroid carcinomas in cell culture -- models for future
RT   therapies.";
RL   Wien. Klin. Wochenschr. 114:279-283(2002).
//
RX   PubMed=15126569; DOI=10.1210/jc.2003-031314;
RA   Kaczirek K., Schindl M., Weinhausel A., Scheuba C., Passler C.,
RA   Prager G., Raderer M., Hamilton G., Mittlbock M., Siegl V.,
RA   Pfragner R., Niederle B.;
RT   "Cytotoxic activity of camptothecin and paclitaxel in newly
RT   established continuous human medullary thyroid carcinoma cell lines.";
RL   J. Clin. Endocrinol. Metab. 89:2397-2401(2004).
//
RX   PubMed=17786610; DOI=10.1080/14653240701385836;
RA   Stadler G., Wieser M., Steindl F., Grillari J., Katinger H.,
RA   Pfragner R., Voglauer R.;
RT   "Development of standarDIzed cell culture conditions for tumor cells
RT   with potential clinical application.";
RL   Cytotherapy 9:488-498(2007).
//